Equities
  • Price (EUR)0.008
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change-65.22%
  • Beta2.9722
Data delayed at least 15 minutes, as of Feb 16 2026 07:06 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Elixinol Wellness Limited is a global health and wellness company. The Company is engaged in marketing and selling hemp and other plant-derived food, skincare, and nutraceutical products. In Australia, it operates a vertically integrated business, which produces, manufactures, and distributes a range of quality products delivered across four verticals: human nutrition, human wellness, pet wellness and superfood ingredients. These products are sold under brands, including Hemp Foods Australia, The Healthy Chef, Mt Elephant, Soul Seed, Field Day, and The Australian Superfood Co, through grocery, wholesale, and e-commerce channels. In the Americas, it is engaged in marketing and selling quality Elixinol branded hemp and other plant-derived nutraceutical and skincare products. In the United Kingdom, Japan, Brazil, Mexico and South Africa, branded hemp and other plant-derived products are available to consumers via exclusive distribution and/or trademark and know-how licensing agreements.

  • Revenue in AUD (TTM)15.84m
  • Net income in AUD-2.06m
  • Incorporated2017
  • Employees--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.